88 related articles for article (PubMed ID: 7524493)
21. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
22. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
Jarvis MF; Gessner GW; Martin GE; Jaye M; Ravera MW; Dionne CA
J Pharmacol Exp Ther; 1992 Oct; 263(1):253-63. PubMed ID: 1383494
[TBL] [Abstract][Full Text] [Related]
23. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.
Hecht D; Zimmerman N; Bedford M; Avivi A; Yayon A
Growth Factors; 1995; 12(3):223-33. PubMed ID: 8619928
[TBL] [Abstract][Full Text] [Related]
24. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
[TBL] [Abstract][Full Text] [Related]
25. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a biologically active extracellular domain of fibroblast growth factor receptor 1 expressed in Escherichia coli.
Bergonzoni L; Caccia P; Cletini O; Sarmientos P; Isacchi A
Eur J Biochem; 1992 Dec; 210(3):823-29. PubMed ID: 1336458
[TBL] [Abstract][Full Text] [Related]
27. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
28. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
[TBL] [Abstract][Full Text] [Related]
29. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
Aviezer D; Safran M; Yayon A
Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
[TBL] [Abstract][Full Text] [Related]
30. Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines.
Ogasawara S; Yano H; Iemura A; Hisaka T; Kojiro M
Hepatology; 1996 Jul; 24(1):198-205. PubMed ID: 8707262
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
32. Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase.
Kouhara H; Kurebayashi S; Hashimoto K; Kasayama S; Koga M; Kishimoto T; Sato B
Oncogene; 1995 Jun; 10(12):2315-22. PubMed ID: 7784079
[TBL] [Abstract][Full Text] [Related]
33. Structural and biosynthetic characterization of the fibroblast growth factor receptor 3 (FGFR-3) protein.
Keegan K; Meyer S; Hayman MJ
Oncogene; 1991 Dec; 6(12):2229-36. PubMed ID: 1662791
[TBL] [Abstract][Full Text] [Related]
34. Modulation of mitogenic activity of fibroblast growth factors by inorganic polyphosphate.
Shiba T; Nishimura D; Kawazoe Y; Onodera Y; Tsutsumi K; Nakamura R; Ohshiro M
J Biol Chem; 2003 Jul; 278(29):26788-92. PubMed ID: 12740373
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of recombinant human acidic fibroblast growth factor produced in E. coli: comparative studies with human basic fibroblast growth factor.
Watanabe T; Seno M; Sasada R; Igarashi K
Mol Endocrinol; 1990 Jun; 4(6):869-79. PubMed ID: 1700280
[TBL] [Abstract][Full Text] [Related]
36. Copper and calcium binding motifs in the extracellular domains of fibroblast growth factor receptors.
Patstone G; Maher P
J Biol Chem; 1996 Feb; 271(7):3343-6. PubMed ID: 8631930
[TBL] [Abstract][Full Text] [Related]
37. Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart.
Kardami E; Liu L; Pasumarthi SK; Doble BW; Cattini PA
Ann N Y Acad Sci; 1995 Mar; 752():353-69. PubMed ID: 7755280
[No Abstract] [Full Text] [Related]
38. A soluble form of K-sam/FGFR2 protein in the culture medium of human gastric cancer cells.
Kishi T; Yoshida T; Terada M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1387-94. PubMed ID: 8060318
[TBL] [Abstract][Full Text] [Related]
39. Purification of an active receptor for acidic and basic fibroblast growth factor from bovine retina.
Torriglia A; Blanquet PR
Biochim Biophys Acta; 1992 Oct; 1137(2):215-24. PubMed ID: 1384713
[TBL] [Abstract][Full Text] [Related]
40. Expression and biological activity of mouse fibroblast growth factor-9.
Santos-Ocampo S; Colvin JS; Chellaiah A; Ornitz DM
J Biol Chem; 1996 Jan; 271(3):1726-31. PubMed ID: 8576175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
